This brand name is authorized in Austria, Estonia, Spain, Finland, France, Croatia, Ireland, Lithuania, Netherlands, Poland, United Kingdom
The drug CINQAERO contains one active pharmaceutical ingredient (API):
|
1
Reslizumab
UNII 35A26E427H - RESLIZUMAB
|
|
Reslizumab is a humanised monoclonal antibody (IgG4, κ) against the human interleukin-5 (IL-5). Reslizumab binds specifically to IL-5 and interferes with IL-5 binding to its cell-surface receptor. IL-5 is a key cytokine responsible for the differentiation, maturation, recruitment and activation of human eosinophils. Reslizumab binds human IL-5 with picomolar affinity blocking its biological function; consequently survival and activity of eosinophils are reduced. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| CINQAERO Concentrate for solution for infusion | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| R03DX08 | R Respiratory system → R03 Drugs for obstructive airway diseases → R03D Other systemic drugs for obstructive airway diseases → R03DX Other systemic drugs for obstructive airway diseases | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1727658, 1744512, 1780297, 1780309 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 1161125001 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 163909, 509173 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 68986222 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 339800, 348091 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1080800, 1083149, 1084987, 1084988 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 135097, 143693 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100374200 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
